EichorEICHOR
Study identifier: NCT01693692 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: Completed

Phase 2 Study of TD-9855 to Treat Fibromyalgia

Condition: Fibromyalgia  ·  Sponsor: Theravance Biopharma

PhasePhase 2
Planned participants392
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNoCheck eligibility criteria ↓
Where34 locations

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The purpose of this study study is to determine whether TD-9855 is effective in treating patients with fibromyalgia.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * • American College of Rheumatology (ACR) Diagnostic Criteria for Fibromyalgia (FM) * Informed consent * 18 to 65 years of age * Discontinue therapy with adrenergic-acting drugs, and certain other medications * Only acetaminophen or NSAID as rescue pain medication * No narcotic pain meds or benzodiazepines * Only non-benzodiazepines as rescue hypnotics Exclusion Criteria: * Any current psychiatric disorder, lifetime bipolar disorder, severe comorbid Axis II disorder, mental retardation, etc, as assessed by Mini International Neuropsychiatric Interview (MINI) * Major depression at screening by MINI when unable to be washed out of MDD meds (investigator or provider's judgment) * Risk of suicide (investigator opinion and/or C-SSRS) * Recent history of substance or alcohol abuse * BMI \<18 or ≥45 * Concurrent disease; pain for diagnosed illness other than FM; non-compliance; history of seizures; pheochromocytoma; glaucoma; CV disease; orthostatic hypotension or orthostatic tachycardia; untreated sleep apnea * Abnormal lab values (liver, kidney, thyroid, and others)

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (34)

Rheumatology Associates of North Alabama, PCHuntsville, Alabama, United States
Dedicated Clinical ResearchGoodyear, Arizona, United States
TriWest Research Associates, LLCEl Cajon, California, United States
Arroyo Medical Group, Inc.Pismo Beach, California, United States
Diablo Clinical Research, Inc.Walnut Creek, California, United States
Coastal Connecticut Research, LLCNew London, Connecticut, United States
Florida Clinical Research Center, LLCBradenton, Florida, United States
PAB Clinical ResearchBrandon, Florida, United States
Meridien ResearchLakeland, Florida, United States
Renstar Medical ResearchOcala, Florida, United States
Compass Research, LLCOrlando, Florida, United States
Clinical Investigation Specialists, Inc.Gurnee, Illinois, United States

+ 22 more locations — full list on the registry record.

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

HuntsvilleGoodyearEl CajonPismo Beach

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →